Health plans support use of mail order, generics - Health plans support use of mail order, generics - Drug Topics

ADVERTISEMENT

Health plans support use of mail order, generics
Health plans support use of mail order, generics

Drug Topics E-News

According to a recent study of health plan sponsors conducted by ReedHaldyMcIntosh for Medco's Systemed Group, 90% of respondents currently use strategies that encourage the use of mail order and 38% have rules that require it. The study also found that nearly 70% of respondents believe stronger incentive programs, including those that require or encourage the use of generics, will have the greatest impact on controlling plan costs. Virtually every plan sponsor (98%) currently employs methods that encourage the use of generic and plan-preferred brands. The research firm polled 200 plan sponsors with 1,000 to 15,000 employees, including private- and public-sector employers and labor unions.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

ADVERTISEMENT

Survey
How much trouble do you have dealing with doctors' bad handwriting?
It's a minor inconvenience
It's a problem from time to time
It's a source of ongoing frustration
Don't get me started!
It's a minor inconvenience
9%
It's a problem from time to time
35%
It's a source of ongoing frustration
35%
Don't get me started!
21%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Source: Drug Topics E-News,
Click here